APO Research
Talk to an analyst

APO RESEARCH · REPORT

RGD Peptide

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global RGD Peptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025191 pages

Choose your research edition.

Industry ResearchRGD Peptide Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal RGD Peptide Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal RGD Peptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RGD Peptide Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal RGD Peptide Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global RGD Peptide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for RGD Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for RGD Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for RGD Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for RGD Peptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of RGD Peptide include Wuhan Tanda Biotechnology, XIAN RUIXI, QYAOBIO, TGpeptide, Merck KGaA, Allpeptide, TargetMol Chemicals, Santa Cruz Animal Health and PEPTIDE INSTITUTE, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines RGD Peptide output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of RGD Peptide by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global RGD Peptide market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of RGD Peptide and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents RGD Peptide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the RGD Peptide market size, projected growth trends, production technologies, key applications, and end-use industries.

RGD Peptide Segment by Company

Wuhan Tanda Biotechnology

XIAN RUIXI

QYAOBIO

TGpeptide

Merck KGaA

Allpeptide

TargetMol Chemicals

Santa Cruz Animal Health

PEPTIDE INSTITUTE

Novatein Biosciences

Enzo

Cell Guidance Systems

CD Bioparticles

Bio-Techne

BICO(Advanced BioMatrix)

ApexBio Technology

AnaSpec

Abbiotec

RGD Peptide Segment by Type

RGD Cyclic Peptide

Linear RGD Peptide

RGD Peptide Segment by Application

Pharmaceuticals

Scientific Research

RGD Peptide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RGD Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RGD Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RGD Peptide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the RGD Peptide market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global RGD Peptide industry.

Chapter 3: Detailed analysis of RGD Peptide market competition landscape. Including RGD Peptide manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of RGD Peptide by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of RGD Peptide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. RGD Peptide Industry Trends Table 2. RGD Peptide Industry Drivers Table 3. RGD Peptide Industry Opportunities and Challenges Table 4. RGD Peptide Industry Restraints Table 5. Global RGD Peptide Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global RGD Peptide Production Value Share by Manufacturers (2021-2026) Table 7. Global RGD Peptide Production by Manufacturers (L) & (2021-2026) Table 8. Global RGD Peptide Production Market Share by Manufacturers Table 9. Global RGD Peptide Average Price (US$/mL) of Manufacturers (2021-2026) Table 10. Global RGD Peptide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global RGD Peptide Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global RGD Peptide Manufacturers, Product Type & Application Table 13. Global RGD Peptide Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global RGD Peptide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of RGD Cyclic Peptide Table 17. Major Manufacturers of Linear RGD Peptide Table 18. Global RGD Peptide Production by Type 2021 VS 2025 VS 2032 (L) Table 19. Global RGD Peptide Production by Type (2021-2026) & (L) Table 20. Global RGD Peptide Production by Type (2027-2032) & (L) Table 21. Global RGD Peptide Production Market Share by Type (2021-2026) Table 22. Global RGD Peptide Production Market Share by Type (2027-2032) Table 23. Global RGD Peptide Production Value by Type 2021 VS 2025 VS 2032 (L) Table 24. Global RGD Peptide Production Value by Type (2021-2026) & (L) Table 25. Global RGD Peptide Production Value by Type (2027-2032) & (L) Table 26. Global RGD Peptide Production Value Market Share by Type (2021-2026) Table 27. Global RGD Peptide Production Value Market Share by Type (2027-2032) Table 28. Major Manufacturers of Pharmaceuticals Table 29. Major Manufacturers of Scientific Research Table 30. Global RGD Peptide Production by Application 2021 VS 2025 VS 2032 (L) Table 31. Global RGD Peptide Production by Application (2021-2026) & (L) Table 32. Global RGD Peptide Production by Application (2027-2032) & (L) Table 33. Global RGD Peptide Production Market Share by Application (2021-2026) Table 34. Global RGD Peptide Production Market Share by Application (2027-2032) Table 35. Global RGD Peptide Production Value by Application 2021 VS 2025 VS 2032 (L) Table 36. Global RGD Peptide Production Value by Application (2021-2026) & (L) Table 37. Global RGD Peptide Production Value by Application (2027-2032) & (L) Table 38. Global RGD Peptide Production Value Market Share by Application (2021-2026) Table 39. Global RGD Peptide Production Value Market Share by Application (2027-2032) Table 40. Wuhan Tanda Biotechnology Company Information Table 41. Wuhan Tanda Biotechnology Business Overview Table 42. Wuhan Tanda Biotechnology RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 43. Wuhan Tanda Biotechnology RGD Peptide Product Portfolio Table 44. Wuhan Tanda Biotechnology Recent Development Table 45. XIAN RUIXI Company Information Table 46. XIAN RUIXI Business Overview Table 47. XIAN RUIXI RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 48. XIAN RUIXI RGD Peptide Product Portfolio Table 49. XIAN RUIXI Recent Development Table 50. QYAOBIO Company Information Table 51. QYAOBIO Business Overview Table 52. QYAOBIO RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 53. QYAOBIO RGD Peptide Product Portfolio Table 54. QYAOBIO Recent Development Table 55. TGpeptide Company Information Table 56. TGpeptide Business Overview Table 57. TGpeptide RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 58. TGpeptide RGD Peptide Product Portfolio Table 59. TGpeptide Recent Development Table 60. Merck KGaA Company Information Table 61. Merck KGaA Business Overview Table 62. Merck KGaA RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 63. Merck KGaA RGD Peptide Product Portfolio Table 64. Merck KGaA Recent Development Table 65. Allpeptide Company Information Table 66. Allpeptide Business Overview Table 67. Allpeptide RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 68. Allpeptide RGD Peptide Product Portfolio Table 69. Allpeptide Recent Development Table 70. TargetMol Chemicals Company Information Table 71. TargetMol Chemicals Business Overview Table 72. TargetMol Chemicals RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 73. TargetMol Chemicals RGD Peptide Product Portfolio Table 74. TargetMol Chemicals Recent Development Table 75. Santa Cruz Animal Health Company Information Table 76. Santa Cruz Animal Health Business Overview Table 77. Santa Cruz Animal Health RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 78. Santa Cruz Animal Health RGD Peptide Product Portfolio Table 79. Santa Cruz Animal Health Recent Development Table 80. PEPTIDE INSTITUTE Company Information Table 81. PEPTIDE INSTITUTE Business Overview Table 82. PEPTIDE INSTITUTE RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 83. PEPTIDE INSTITUTE RGD Peptide Product Portfolio Table 84. PEPTIDE INSTITUTE Recent Development Table 85. Novatein Biosciences Company Information Table 86. Novatein Biosciences Business Overview Table 87. Novatein Biosciences RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 88. Novatein Biosciences RGD Peptide Product Portfolio Table 89. Novatein Biosciences Recent Development Table 90. Enzo Company Information Table 91. Enzo Business Overview Table 92. Enzo RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 93. Enzo RGD Peptide Product Portfolio Table 94. Enzo Recent Development Table 95. Cell Guidance Systems Company Information Table 96. Cell Guidance Systems Business Overview Table 97. Cell Guidance Systems RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 98. Cell Guidance Systems RGD Peptide Product Portfolio Table 99. Cell Guidance Systems Recent Development Table 100. CD Bioparticles Company Information Table 101. CD Bioparticles Business Overview Table 102. CD Bioparticles RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 103. CD Bioparticles RGD Peptide Product Portfolio Table 104. CD Bioparticles Recent Development Table 105. Bio-Techne Company Information Table 106. Bio-Techne Business Overview Table 107. Bio-Techne RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 108. Bio-Techne RGD Peptide Product Portfolio Table 109. Bio-Techne Recent Development Table 110. BICO(Advanced BioMatrix) Company Information Table 111. BICO(Advanced BioMatrix) Business Overview Table 112. BICO(Advanced BioMatrix) RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 113. BICO(Advanced BioMatrix) RGD Peptide Product Portfolio Table 114. BICO(Advanced BioMatrix) Recent Development Table 115. ApexBio Technology Company Information Table 116. ApexBio Technology Business Overview Table 117. ApexBio Technology RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 118. ApexBio Technology RGD Peptide Product Portfolio Table 119. ApexBio Technology Recent Development Table 120. AnaSpec Company Information Table 121. AnaSpec Business Overview Table 122. AnaSpec RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 123. AnaSpec RGD Peptide Product Portfolio Table 124. AnaSpec Recent Development Table 125. Abbiotec Company Information Table 126. Abbiotec Business Overview Table 127. Abbiotec RGD Peptide Production (L), Value (US$ Million), Price (US$/mL) and Gross Margin (2021-2026) Table 128. Abbiotec RGD Peptide Product Portfolio Table 129. Abbiotec Recent Development Table 130. Global RGD Peptide Production by Region: 2021 VS 2025 VS 2032 (L) Table 131. Global RGD Peptide Production by Region (2021-2026) & (L) Table 132. Global RGD Peptide Production Market Share by Region (2021-2026) Table 133. Global RGD Peptide Production Forecast by Region (2027-2032) & (L) Table 134. Global RGD Peptide Production Market Share Forecast by Region (2027-2032) Table 135. Global RGD Peptide Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 136. Global RGD Peptide Production Value by Region (2021-2026) & (US$ Million) Table 137. Global RGD Peptide Production Value Share by Region (2021-2026) Table 138. Global RGD Peptide Production Value by Region (2027-2032) & (US$ Million) Table 139. Global RGD Peptide Production Value Share by Region: (2027-2032) & (US$ Million) Table 140. Global RGD Peptide Market Average Price (US$/mL) by Region (2021-2026) Table 141. Global RGD Peptide Market Average Price (US$/mL) by Region (2027-2032) Table 142. Global RGD Peptide Consumption by Region: 2021 VS 2025 VS 2032 (L) Table 143. Global RGD Peptide Consumption by Region (2021-2026) & (L) Table 144. Global RGD Peptide Consumption Market Share by Region (2021-2026) Table 145. Global RGD Peptide Consumption Forecasted by Region (2027-2032) & (L) Table 146. Global RGD Peptide Consumption Forecasted Market Share by Region (2027-2032) Table 147. North America RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 148. North America RGD Peptide Consumption by Country (2021-2026) & (L) Table 149. North America RGD Peptide Consumption by Country (2027-2032) & (L) Table 150. Europe RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 151. Europe RGD Peptide Consumption by Country (2021-2026) & (L) Table 152. Europe RGD Peptide Consumption by Country (2027-2032) & (L) Table 153. Asia Pacific RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 154. Asia Pacific RGD Peptide Consumption by Country (2021-2026) & (L) Table 155. Asia Pacific RGD Peptide Consumption by Country (2027-2032) & (L) Table 156. South America RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 157. South America RGD Peptide Consumption by Country (2021-2026) & (L) Table 158. South America RGD Peptide Consumption by Country (2027-2032) & (L) Table 159. Middle East & Africa RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 160. Middle East & Africa RGD Peptide Consumption by Country (2021-2026) & (L) Table 161. Middle East & Africa RGD Peptide Consumption by Country (2027-2032) & (L) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. RGD Peptide Distributors List Table 165. RGD Peptide Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. RGD Peptide Product Image Figure 2. Global RGD Peptide Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global RGD Peptide Production Value (2021-2032) & (US$ Million) Figure 4. Global RGD Peptide Production Capacity (2021-2032) & (L) Figure 5. Global RGD Peptide Production (2021-2032) & (L) Figure 6. Global RGD Peptide Average Price (US$/mL) & (2021-2032) Figure 7. Global Top 5 and 10 RGD Peptide Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. RGD Cyclic Peptide Image Figure 10. Linear RGD Peptide Image Figure 11. Global RGD Peptide Production by Type (2021 VS 2025 VS 2032) & (L) Figure 12. Global RGD Peptide Production Market Share 2021 VS 2025 VS 2032 Figure 13. Global RGD Peptide Production Market Share by Type (2021-2032) Figure 14. Global RGD Peptide Production Value by Type (2021 VS 2025 VS 2032) & (L) Figure 15. Global RGD Peptide Production Value Share 2021 VS 2025 VS 2032 Figure 16. Global RGD Peptide Production Value Share by Type (2021-2032) Figure 17. Pharmaceuticals Image Figure 18. Scientific Research Image Figure 19. Global RGD Peptide Production by Application (2021 VS 2025 VS 2032) & (L) Figure 20. Global RGD Peptide Production Market Share 2021 VS 2025 VS 2032 Figure 21. Global RGD Peptide Production Market Share by Application (2021-2032) Figure 22. Global RGD Peptide Production Value by Application (2021 VS 2025 VS 2032) & (L) Figure 23. Global RGD Peptide Production Value Share 2021 VS 2025 VS 2032 Figure 24. Global RGD Peptide Production Value Share by Application (2021-2032) Figure 25. Global RGD Peptide Production by Region: 2021 VS 2025 VS 2032 (L) Figure 26. Global RGD Peptide Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global RGD Peptide Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global RGD Peptide Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America RGD Peptide Production Value (2021-2032) & (US$ Million) Figure 30. Europe RGD Peptide Production Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific RGD Peptide Production Value (2021-2032) & (US$ Million) Figure 32. South America RGD Peptide Production Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa RGD Peptide Production Value (2021-2032) & (US$ Million) Figure 34. North America RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 35. North America RGD Peptide Consumption Market Share by Country (2021-2032) Figure 36. U.S. RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 37. Canada RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 38. Mexico RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 39. Europe RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 40. Europe RGD Peptide Consumption Market Share by Country (2021-2032) Figure 41. Germany RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 42. France RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 43. U.K. RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 44. Italy RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 45. Netherlands RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 46. Asia Pacific RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 47. Asia Pacific RGD Peptide Consumption Market Share by Country (2021-2032) Figure 48. China RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 49. Japan RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 50. South Korea RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 51. Southeast Asia RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 52. India RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 53. Australia RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 54. South America RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 55. South America RGD Peptide Consumption Market Share by Country (2021-2032) Figure 56. Mexico RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 57. Brazil RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 58. Argentina RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 59. Middle East & Africa RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 60. Middle East & Africa RGD Peptide Consumption Market Share by Country (2021-2032) Figure 61. Turkey RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 62. Saudi Arabia RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 63. UAE RGD Peptide Consumption and Growth Rate (2021-2032) & (L) Figure 64. RGD Peptide Value Chain Figure 65. Manufacturing Cost Structure Figure 66. RGD Peptide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • RGD Cyclic Peptide
  • Linear RGD Peptide
Applications
  • Pharmaceuticals
  • Scientific Research
Companies covered
  • Wuhan Tanda Biotechnology
  • XIAN RUIXI
  • QYAOBIO
  • TGpeptide
  • Merck KGaA
  • Allpeptide
  • TargetMol Chemicals
  • Santa Cruz Animal Health
  • PEPTIDE INSTITUTE
  • Novatein Biosciences
  • Enzo
  • Cell Guidance Systems
  • CD Bioparticles
  • Bio-Techne
  • BICO(Advanced BioMatrix)
  • ApexBio Technology
  • AnaSpec
  • Abbiotec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global RGD Peptide Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global RGD Peptide Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global RGD Peptide Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global RGD Peptide Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global RGD Peptide Market Dynamics
  1. 2.1 RGD Peptide Industry Trends
  2. 2.2 RGD Peptide Industry Drivers
  3. 2.3 RGD Peptide Industry Opportunities and Challenges
  4. 2.4 RGD Peptide Industry Restraints
3 RGD Peptide Market by Manufacturers
  1. 3.1 Global RGD Peptide Production Value by Manufacturers (2021-2026)
  2. 3.2 Global RGD Peptide Production by Manufacturers (2021-2026)
  3. 3.3 Global RGD Peptide Average Price by Manufacturers (2021-2026)
  4. 3.4 Global RGD Peptide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global RGD Peptide Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global RGD Peptide Manufacturers, Product Type & Application
  7. 3.7 Global RGD Peptide Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global RGD Peptide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 RGD Peptide Players Market Share by Production Value in 2025
  11. 3.8.3 2025 RGD Peptide Tier 1, Tier 2, and Tier 3
4 RGD Peptide Market by Type
  1. 4.1 RGD Peptide Type Introduction
  2. 4.1.1 RGD Cyclic Peptide
  3. 4.1.2 Linear RGD Peptide
  4. 4.2 Global RGD Peptide Production by Type
  5. 4.2.1 Global RGD Peptide Production by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global RGD Peptide Production by Type (2021-2032)
  7. 4.2.3 Global RGD Peptide Production Market Share by Type (2021-2032)
  8. 4.3 Global RGD Peptide Production Value by Type
  9. 4.3.1 Global RGD Peptide Production Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global RGD Peptide Production Value by Type (2021-2032)
  11. 4.3.3 Global RGD Peptide Production Value Market Share by Type (2021-2032)
5 RGD Peptide Market by Application
  1. 5.1 RGD Peptide Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Scientific Research
  4. 5.2 Global RGD Peptide Production by Application
  5. 5.2.1 Global RGD Peptide Production by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global RGD Peptide Production by Application (2021-2032)
  7. 5.2.3 Global RGD Peptide Production Market Share by Application (2021-2032)
  8. 5.3 Global RGD Peptide Production Value by Application
  9. 5.3.1 Global RGD Peptide Production Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global RGD Peptide Production Value by Application (2021-2032)
  11. 5.3.3 Global RGD Peptide Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Wuhan Tanda Biotechnology
  2. 6.1.1 Wuhan Tanda Biotechnology Company Information
  3. 6.1.2 Wuhan Tanda Biotechnology Business Overview
  4. 6.1.3 Wuhan Tanda Biotechnology RGD Peptide Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Wuhan Tanda Biotechnology RGD Peptide Product Portfolio
  6. 6.1.5 Wuhan Tanda Biotechnology Recent Developments
  7. 6.2 XIAN RUIXI
  8. 6.2.1 XIAN RUIXI Company Information
  9. 6.2.2 XIAN RUIXI Business Overview
  10. 6.2.3 XIAN RUIXI RGD Peptide Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 XIAN RUIXI RGD Peptide Product Portfolio
  12. 6.2.5 XIAN RUIXI Recent Developments
  13. 6.3 QYAOBIO
  14. 6.3.1 QYAOBIO Company Information
  15. 6.3.2 QYAOBIO Business Overview
  16. 6.3.3 QYAOBIO RGD Peptide Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 QYAOBIO RGD Peptide Product Portfolio
  18. 6.3.5 QYAOBIO Recent Developments
  19. 6.4 TGpeptide
  20. 6.4.1 TGpeptide Company Information
  21. 6.4.2 TGpeptide Business Overview
  22. 6.4.3 TGpeptide RGD Peptide Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 TGpeptide RGD Peptide Product Portfolio
  24. 6.4.5 TGpeptide Recent Developments
  25. 6.5 Merck KGaA
  26. 6.5.1 Merck KGaA Company Information
  27. 6.5.2 Merck KGaA Business Overview
  28. 6.5.3 Merck KGaA RGD Peptide Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Merck KGaA RGD Peptide Product Portfolio
  30. 6.5.5 Merck KGaA Recent Developments
  31. 6.6 Allpeptide
  32. 6.6.1 Allpeptide Company Information
  33. 6.6.2 Allpeptide Business Overview
  34. 6.6.3 Allpeptide RGD Peptide Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Allpeptide RGD Peptide Product Portfolio
  36. 6.6.5 Allpeptide Recent Developments
  37. 6.7 TargetMol Chemicals
  38. 6.7.1 TargetMol Chemicals Company Information
  39. 6.7.2 TargetMol Chemicals Business Overview
  40. 6.7.3 TargetMol Chemicals RGD Peptide Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 TargetMol Chemicals RGD Peptide Product Portfolio
  42. 6.7.5 TargetMol Chemicals Recent Developments
  43. 6.8 Santa Cruz Animal Health
  44. 6.8.1 Santa Cruz Animal Health Company Information
  45. 6.8.2 Santa Cruz Animal Health Business Overview
  46. 6.8.3 Santa Cruz Animal Health RGD Peptide Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 Santa Cruz Animal Health RGD Peptide Product Portfolio
  48. 6.8.5 Santa Cruz Animal Health Recent Developments
  49. 6.9 PEPTIDE INSTITUTE
  50. 6.9.1 PEPTIDE INSTITUTE Company Information
  51. 6.9.2 PEPTIDE INSTITUTE Business Overview
  52. 6.9.3 PEPTIDE INSTITUTE RGD Peptide Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 PEPTIDE INSTITUTE RGD Peptide Product Portfolio
  54. 6.9.5 PEPTIDE INSTITUTE Recent Developments
  55. 6.10 Novatein Biosciences
  56. 6.10.1 Novatein Biosciences Company Information
  57. 6.10.2 Novatein Biosciences Business Overview
  58. 6.10.3 Novatein Biosciences RGD Peptide Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Novatein Biosciences RGD Peptide Product Portfolio
  60. 6.10.5 Novatein Biosciences Recent Developments
  61. 6.11 Enzo
  62. 6.11.1 Enzo Company Information
  63. 6.11.2 Enzo Business Overview
  64. 6.11.3 Enzo RGD Peptide Production, Value and Gross Margin (2021-2026)
  65. 6.11.4 Enzo RGD Peptide Product Portfolio
  66. 6.11.5 Enzo Recent Developments
  67. 6.12 Cell Guidance Systems
  68. 6.12.1 Cell Guidance Systems Company Information
  69. 6.12.2 Cell Guidance Systems Business Overview
  70. 6.12.3 Cell Guidance Systems RGD Peptide Production, Value and Gross Margin (2021-2026)
  71. 6.12.4 Cell Guidance Systems RGD Peptide Product Portfolio
  72. 6.12.5 Cell Guidance Systems Recent Developments
  73. 6.13 CD Bioparticles
  74. 6.13.1 CD Bioparticles Company Information
  75. 6.13.2 CD Bioparticles Business Overview
  76. 6.13.3 CD Bioparticles RGD Peptide Production, Value and Gross Margin (2021-2026)
  77. 6.13.4 CD Bioparticles RGD Peptide Product Portfolio
  78. 6.13.5 CD Bioparticles Recent Developments
  79. 6.14 Bio-Techne
  80. 6.14.1 Bio-Techne Company Information
  81. 6.14.2 Bio-Techne Business Overview
  82. 6.14.3 Bio-Techne RGD Peptide Production, Value and Gross Margin (2021-2026)
  83. 6.14.4 Bio-Techne RGD Peptide Product Portfolio
  84. 6.14.5 Bio-Techne Recent Developments
  85. 6.15 BICO(Advanced BioMatrix)
  86. 6.15.1 BICO(Advanced BioMatrix) Company Information
  87. 6.15.2 BICO(Advanced BioMatrix) Business Overview
  88. 6.15.3 BICO(Advanced BioMatrix) RGD Peptide Production, Value and Gross Margin (2021-2026)
  89. 6.15.4 BICO(Advanced BioMatrix) RGD Peptide Product Portfolio
  90. 6.15.5 BICO(Advanced BioMatrix) Recent Developments
  91. 6.16 ApexBio Technology
  92. 6.16.1 ApexBio Technology Company Information
  93. 6.16.2 ApexBio Technology Business Overview
  94. 6.16.3 ApexBio Technology RGD Peptide Production, Value and Gross Margin (2021-2026)
  95. 6.16.4 ApexBio Technology RGD Peptide Product Portfolio
  96. 6.16.5 ApexBio Technology Recent Developments
  97. 6.17 AnaSpec
  98. 6.17.1 AnaSpec Company Information
  99. 6.17.2 AnaSpec Business Overview
  100. 6.17.3 AnaSpec RGD Peptide Production, Value and Gross Margin (2021-2026)
  101. 6.17.4 AnaSpec RGD Peptide Product Portfolio
  102. 6.17.5 AnaSpec Recent Developments
  103. 6.18 Abbiotec
  104. 6.18.1 Abbiotec Company Information
  105. 6.18.2 Abbiotec Business Overview
  106. 6.18.3 Abbiotec RGD Peptide Production, Value and Gross Margin (2021-2026)
  107. 6.18.4 Abbiotec RGD Peptide Product Portfolio
  108. 6.18.5 Abbiotec Recent Developments
7 Global RGD Peptide Production by Region
  1. 7.1 Global RGD Peptide Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global RGD Peptide Production by Region (2021-2032)
  3. 7.2.1 Global RGD Peptide Production by Region (2021-2026)
  4. 7.2.2 Global RGD Peptide Production Forecast by Region (2027-2032)
  5. 7.3 Global RGD Peptide Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global RGD Peptide Production Value by Region (2021-2032)
  7. 7.4.1 Global RGD Peptide Production Value by Region (2021-2026)
  8. 7.4.2 Global RGD Peptide Production Value by Region (2027-2032)
  9. 7.5 Global RGD Peptide Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America RGD Peptide Production Value (2021-2032)
  12. 7.6.2 Europe RGD Peptide Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific RGD Peptide Production Value (2021-2032)
  14. 7.6.4 South America RGD Peptide Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa RGD Peptide Production Value (2021-2032)
8 Global RGD Peptide Consumption by Region
  1. 8.1 Global RGD Peptide Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global RGD Peptide Consumption by Region (2021-2032)
  3. 8.2.1 Global RGD Peptide Consumption by Region (2021-2026)
  4. 8.2.2 Global RGD Peptide Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America RGD Peptide Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe RGD Peptide Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific RGD Peptide Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America RGD Peptide Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa RGD Peptide Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa RGD Peptide Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 RGD Peptide Value Chain Analysis
  2. 9.1.1 RGD Peptide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 RGD Peptide Production Mode & Process
  6. 9.2 RGD Peptide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 RGD Peptide Distributors
  9. 9.2.3 RGD Peptide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst